DataMeds AI, Inc. is classed by the SEC under Wholesale-Drugs, Proprietaries & Druggists' Sundries (industry code 5122), based in Tampa, FL. In its latest annual figures on file, for the fiscal year ended 2025-12-31, it reported revenue of $23 million and a loss of $101 million (its filed statements).
Distribution businessWholesale-Drugs, Proprietaries & Druggists' SundriesTampa, FLfilings since 20245 of 9 filed, 4 estimated
Three tenses, nine metrics. Unseen metrics stay unseen; the grade never fakes a number. Proxy era: provisional values, marked. Weighed as a distribution business: prior from its industry code (SEC 5122, Wholesale-Drugs, Proprietaries & Druggists' Sundries); the filing read can change it. All three tenses have at least two readings, so the archetype blend applies as printed.
The grade, in three tenses
Headline 3.0 out of ten, 5 of 9 metrics filed and 4 estimated: past 2.5 out of ten, present 2.6 out of ten, future 4.1 out of ten. The past asks what it actually did, the present what it is doing right now, the future what it is set up to do next.
The nine metrics
Surviving crises (past): 1.0 out of ten. 9 warning events since 2024; the latest 2026-08-14. 10th percentile among 10 sector filers. A production reading, recomputed from the filings on every data build (read from EDGAR 2026-10-12).
Track record (past): 4.5 out of ten. CrossAssetData estimate 4.5/10, confidence 20 of 100 (family median). 50th percentile among 8 sector filers. A CrossAssetData estimate, not a filed reading: family median, confidence 20 of 100; its next annual report on file with the inputs replaces this estimate with the filed reading.
Shareholder treatment (past): 2.5 out of ten. CrossAssetData estimate 2.5/10, confidence 35 of 100 (one part). 25th percentile among 10 sector filers. A CrossAssetData estimate, not a filed reading: one part, confidence 35 of 100; a filing that carries the missing parts replaces this estimate with the filed reading.
Financial health (present): 1.5 out of ten. Leverage 141%: owes 141¢ per asset dollar. 15th percentile among 10 sector filers. A production reading, recomputed from the filings on every data build (read from EDGAR 2026-10-12).
Industry position (present): 4.2 out of ten. bottom 42% of 10 in its family; net margin -433.9%. 42nd percentile among 10 sector filers. A production reading, recomputed from the filings on every data build (read from EDGAR 2026-10-12).
Leadership (present): 1.0 out of ten. bottom 10% of 9 in its family for leadership; chief executive since 2026. 10th percentile among 9 sector filers. A production reading, recomputed from the filings on every data build (read from EDGAR 2026-10-09).
Room to expand (future): 0.8 out of ten. bottom 8% of 10 in its family for room to expand. 8th percentile among 10 sector filers. A production reading, recomputed from the filings on every data build (read from EDGAR 2026-10-12).
Growth drivers (future): 5.9 out of ten. CrossAssetData estimate 5.9/10, confidence 20 of 100 (family median). 50th percentile among 8 sector filers. A CrossAssetData estimate, not a filed reading: family median, confidence 20 of 100; its next annual report on file with the inputs replaces this estimate with the filed reading.
Expectations vs reality (future): 5.5 out of ten. CrossAssetData estimate 5.5/10, confidence 20 of 100 (family median). 50th percentile among 7 sector filers. A CrossAssetData estimate, not a filed reading: family median, confidence 20 of 100; its next annual report on file with the inputs replaces this estimate with the filed reading.
The filing record
Newest annual report: Form 10-K filed 2026-03-20 for the period ended 2025-12-31 (on EDGAR). Newest quarterly report: Form 10-Q filed 2026-08-17 for the period ended 2026-06-30 (on EDGAR). Newest results release: Form 8-K filed 2026-08-18 for the period ended 2026-08-17 (on EDGAR). Newest filing: Form S-1/A, 2026-10-09. Filings on record since 2024. Read from EDGAR 2026-10-12.
Where the revenue comes from
Product and service lines in fiscal 2025: Product 94%, Pharmacy Retail Sales 4%, Third Party Logistics Services 3%. As tagged in its annual report (Form 10-K, filed 2026-03-20).
Who runs it
Patel, Prashant (Chief Executive Officer); Ajjarapu, Surendra K (director); Herman, Gary L (director); Sherb, Eric Michael (director); Velez, Marlene (director); Doss, Howard A. (director); Fell, Donald G. (director); Lee, Steven Dale (director); Peterson, Michael L (director). 9 officers and directors have filed their own trades in the last fifteen months, names and titles as filed with the SEC, through 2026-09-30.
Every stock is a company. We grade the company behind the stock. CrossAssetData is a company research product: no investment advice, no price targets, no price predictions; every claim carries its source, and unseen means unseen. The full file draws when the page's script runs: the essentials, the balance sheet, the estimators, the trend, and every filing of the last ten years.